Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
Cabotegravir
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/16/2020
NH125
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/16/2020
Entacapone
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jun/16/2020
CPI1062 
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/16/2020
CPI1155 
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/16/2020
MDR504 hACE2-Fc
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/15/2020
EY6A
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/13/2020
N3
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/11/2020
Chenodeoxycholic acid
Potential treatment - pre-clinical evidence Natural product Antiviral Jun/11/2020
Obeticholic acid
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/11/2020
BAR704
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/11/2020
BAR501
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/11/2020
BAR502
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/11/2020
Glyco-ursodeoxycholic acid
Potential treatment - pre-clinical evidence Natural product Antiviral Jun/11/2020
Tauro-ursodeoxycholic acid
Potential treatment - pre-clinical evidence Natural product Antiviral Jun/11/2020
Betulinic Acid
Potential treatment - pre-clinical evidence Used to treat other disease Antiviral Jun/11/2020
Glyco-chenodeoxycholic acid
Potential treatment - pre-clinical evidence Natural product Antiviral Jun/11/2020
Magnesium
Potential treatment - clinical evidence Used to treat other disease Other treatment Jun/10/2020
MR3
Potential treatment - pre-clinical evidence Experimental Antiviral Jun/10/2020
anti-IL-1α mAbs
Potential treatment - pre-clinical evidence Experimental Other treatment Jun/08/2020